Max Robotics — Global Service Robot Directory + US Certification

About

Chandan Kundavaram is a urologic surgeon and researcher whose work bridges surgical innovation, cost-effectiveness, and robotic technology in the treatment of prostate and kidney cancers. His most impactful contributions center on applying time-driven activity-based costing (TDABC) to urologic oncology, fundamentally reframing how we understand the true economic burden of cancer care. His landmark 2015 study on the short- and long-term costs of treating localized, low-risk prostate cancer (144 citations) provided one of the first rigorous, process-level cost analyses for competing treatment strategies, offering a data-driven framework for value-based care. In parallel, Kundavaram has been instrumental in advancing robotic surgery, both through the validation of the da Vinci Skills Simulator (120 citations)—a critical tool for training the next generation of robotic surgeons—and through pioneering techniques in robotic vena cava tumor thrombectomy, including intracaval balloon occlusion and vena cavoscopy. His work on the true costs of treating small renal masses further extends his commitment to transparency in healthcare economics. Through these contributions, Kundavaram has established himself as a key voice at the intersection of surgical excellence, cost-conscious care, and robotic innovation.